Arachis oil liquid
Peanut oil is derived from <em>Arachis hypogaea</em> which can be found in South America, Mexico, and Centro America.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Arachis oil
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
6 branded products available
Part of the Fletchers brand family (generic: Arachis oil)
MHRA licensed products
View all licensed products for Arachis oil on the MHRA register
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 29 studies.
2016–2026
Showing all 29 studies, sorted by most relevant.
Xiaoping Chen, Qing Lu, H. Liu, et al.
Molecular plant, 2019
- Arachis
- Whole Genome Sequencing
- Peanut Oil
Xiaoping Chen, Hongjie Li, M. Pandey, et al.
Proceedings of the National Academy of Sciences, 2016
- Arachis
- Plant Proteins
- Tetraploidy
Yaduru Shasidhar, Manish K. Vishwakarma, M. Pandey, et al.
Frontiers in Plant Science, 2017
Enhancing seed oil content with desirable fatty acid composition is one of the most important objectives of groundnut breeding programs globally. Genomics-assisted breeding facilitates combining multiple traits faster, however, requires linked markers. In this context, we have developed two different F2 mapping populations, one for oil content (OC-population, ICGV 07368 × ICGV 06420) and another for fatty acid composition (FA-population, ICGV 06420 × SunOleic 95R). These two populations were phenotyped for respective traits and genotyped using Diversity Array Technology (DArT) and DArTseq genotyping platforms. Two genetic maps were developed with 854 (OC-population) and 1,435 (FA-population) marker loci with total map distance of 3,526 and 1,869 cM, respectively. Quantitative trait locus (QTL) analysis using genotyping and phenotyping data identified eight QTLs for oil content including two major QTLs, qOc-A10 and qOc-A02, with 22.11 and 10.37% phenotypic variance explained (PVE), respectively. For seven different fatty acids, a total of 21 QTLs with range 7.6% to 78.6% PVE were identified and 20 of these QTLs were of major effect. Two mutant alleles, ahFAD2B and ahFAD2A, also had 18.44% and 10.78% PVE for palmitic acid, in addition to oleic (33.8% and 17.4% PVE) and linoleic (41.0% and 19.5% PVE) acids. Furthermore, four QTL clusters harbouring more than three QTLs for fatty acids were identified on the three LGs. The QTLs identified in this study could be further dissected for candidate gene discovery and development of diagnostic markers for breeding improved groundnut varieties with high oil content and desirable oil quality.
Abstract licence: CC BY
Nian Liu, Jianbin Guo, Xiaojing Zhou, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik, 2019
- Peanut Oil
- Base Sequence
- Genetic Markers
KEY MESSAGE: ddRAD-seq-based high-density genetic map comprising 2595 loci identified a major and consensus QTL with a linked marker in a 0.8-Mb physical interval for oil content in peanut. Enhancing oil content is an important breeding objective in peanut. High-resolution mapping of quantitative trait loci (QTLs) with linked markers could facilitate marker-assisted selection in breeding for target traits. In the present study, a recombined inbred line population (Xuhua 13 × Zhonghua 6) was used to construct a genetic map based on double-digest restriction-site-associated DNA sequencing (ddRAD-seq). The resulting high-density genetic map contained 2595 loci, and spanned a length of 2465.62 cM, with an average distance of 0.95 cM/locus. Seven QTLs for oil content were identified on five linkage groups, including the major and stable QTL qOCA08.1 on chromosome A08 with 10.14-27.19% phenotypic variation explained. The physical interval of qOCA08.1 was further delimited to a ~ 0.8-Mb genomic region where two genes affecting oil synthesis had been annotated. The marker SNPOCA08 was developed targeting the SNP loci associated with oil content and validated in peanut cultivars with diverse oil contents. The major and stable QTL identified in the present study could be further dissected for gene discovery. Furthermore, the tightly linked marker for oil content would be useful in marker-assisted breeding in peanut.
Abstract licence: CC BY
Weitao Li, Yiyang Liu, Libin Li, et al.
Journal of agricultural and food chemistry, 2024
- Arachis
- Plant Proteins
- Seeds
Hilary Uguru, O. Akpokodje, Dalia I. Hemdan, et al.
Materials Express, 2023
Bingyan Huang, Hua Liu, Yuan-jin Fang, et al.
Journal of Integrative Agriculture, 2023
Peanut kernels rich in oil, particularly those with oleic acid as their primary fatty acid, are sought after by consumers, the food industry, and farmers due to their superior nutritional content, extended shelf life, and health benefits. The oil content and fatty acid composition are governed by multiple genetic factors. Identifying the quantitative trait loci (QTL) related to these attributes would facilitate marker-assisted selection or genomic selection, thus enhancing the quality-focused peanut breeding program. For this purpose, we developed a population of 521 recombinant inbred lines (RIL) and tested their kernel quality traits across five different environments. We identified two major and stable QTLs for oil content (qOCAh12.1 and qOCAh16.1). The markers linked to these QTLs were designed by competitive allele-specific PCR (KASP) and were subsequently validated. Moreover, we found that the superior haplotype of oil content in the qOCAh16.1 region was conserved within the PI germplasm cluster, as evidenced by a diverse peanut accession panel. In addition, we determined that qAh09 and qAh19.1, which harbor the key gene encoding fatty acid desaturase 2 (FAD2), influence all seven fatty acids, including palmitic, stearic, oleic, linoleic, arachidic, gadoleic, and behenic acids. As for protein content and the long-chain saturated fatty acid behenic acid, qAh07 emerged as the major and stable QTLs, accounting for over 10% of the phenotypic variation explained (PVE). These findings would enhance marker-assisted selection in peanut breeding, aiming to improve oil content, and deepen our understanding of the genetic mechanisms that shape fatty acid composition.
Abstract licence: CC BY-NC-ND
Feifei Wang, H. Miao, Shengzhong Zhang, et al.
Plants, 2025
High oil content in peanut seeds is a key breeding objective for peanut (Arachis hypogaea L.) quality improvement. In order to explore the genetic basis of oil content in peanuts, a recombinant inbred line (RIL) population consisting of 256 lines was phenotyped across six environments. Continuous distribution and transgressive segregation for both oil content and oleic acid content were demonstrated across all environments. Quantitative trait locus (QTL) analysis yielded 15 additive QTLs explaining 4.34 to 23.10% of phenotypic variations. A novel stable and major QTL region conditioning oil content (qOCB09.1) was mapped to chromosome B09, spanning a 1.99 Mb genomic region with 153 putative genes, including the oleic acid gene FAD2B, which may influence the oil content. Candidate genes were identified and diagnostic markers for this region were developed for further investigation. Additionally, 18 pairs of epistatic interactions involving 35 loci were identified to affect the oil content, explaining 1.25 to 1.84% of phenotypic variations. These findings provide valuable insights for further map-based cloning of favorable alleles for oil content in peanuts.
Abstract licence: CC BY
G. Tang, P. Xu, W. Ma, et al.
Frontiers in Plant Science, 2018
Peanut (Arachis hypogaea L.) is one of the major oil crops and is the fifth largest source of plant oils in the world. Numerous genes participate in regulating the biosynthesis and accumulation of the storage lipids in seeds or other reservoir organs, among which several transcription factors, such as LEAFY COTYLEDON1 (AtLEC1), LEC2, and WRINKLED1 (WRI1), involved in embryo development also control the lipid reservoir in seeds. In this study, the AtLEC1 gene was transferred into the peanut genome and expressed in a seed-specific manner driven by the NapinA full-length promoter or its truncated 230-bp promoter. Four homozygous transgenic lines, two lines with the longer promoter and the other two with the truncated one, were selected for further analysis. The AtLEC1 mRNA level and the corresponding protein accumulation in different transgenic overexpression lines were altered, and the transgenic plants grew and developed normally without any detrimental effects on major agronomic traits. In the developing seeds of transgenic peanuts, the mRNA levels of a series of genes were upregulated. These genes are associated with fatty acid biosynthesis and lipid accumulation. The former set of genes included the homomeric ACCase A (AhACC II), the BC subunit of heteromeric ACCase (AhBC4), ketoacyl-ACP synthetase (AhKAS II), and stearoyl-ACP desaturase (AhSAD), while the latter ones were the diacylglycerol acyltransferases and oleosins (AhDGAT1, AhDGAT2, AhOle1, AhOle2, and AhOle3). The oil content and seed weight increased by 4.42%–15.89% and 11.1%–22.2%, respectively, and the levels of major fatty acid (FA) components including stearic acid, oleic acid, and linoleic acid changed significantly in all different lines.
Abstract licence: CC BY
Umer MJ, Huang L, Liu H, et al.
2025
- Plant Breeding
- Arachis
- Genome, Plant
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
When used in laxatives, peanut oil lubricates and softness the feces which promotes bowel movement.
Food interactions
None known
Human targets
None mapped
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Absorption
Half-life
Protein binding
Volume of distribution
Metabolism
120 hours
Elimination
120 hours
Clearance
Pharmacokinetic data: DrugBank · CC BY-NC 4.0
Peanut oil is also used usually to solubilize drugs with poor water solubility as part of the oral formulation.T224
When orally administered, peanut oil has as well been researched and used to prevent heart diseases and lower cholesterol levels as well as to aid in weight loss and decrease appetite.
[L2897]
[A33177]
Ear drops containing peanut oil are usually considered a not "true cerumenolytic". A cerumenolytic causes the breakdown of keratin and wax but the oil-based cerumenolytics only soften and lubricate the wax. The peanut oil contained in this cerumenolytics serve as lubricating agents.T225
Administered topically, peanut oil acts as an emollient which acts by forming an occlusive oil film on the stratum corneum which in order decreases the transepidermal water loss.T226
The use of peanut oil as a cardioprotective strives in the presence of DB14038 and DB02709. As well, the presence of high monounsaturated and low saturated fat content is thought to prevent heart disease and lower cholesterol.[L2897]
Topically administered, peanut oil effect can be observed as a softening and protection of the skin.T226
Some population studies suggest people who eat nuts have a lower risk of developing heart disease. This benefit must be weighed against animal evidence that suggests peanut oil is atherogenic, perhaps due to the triglyceride content or the presence of a lectin.[L2897]
How the body processes this drug — absorption, distribution, metabolism, and elimination
However, the absorption after administration orally or in the mucosa is much more rapid.T227 To know more about the pharmacokinetics of peanut oil, please visit DB04224 as it is its main component.
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Peanut oil
Matched from: Arachis oil
DrugBank citations
If you use DrugBank data in your research, please cite the following publications:
Show earlier publications
Structured knowledge from the free knowledge base
Molecular structure

Linked open data from Wikidata (Q265878), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication. Molecular structure images from Wikimedia Commons.